Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
PR Newswire
PHILADELPHIA, Oct. 8, 2026
- For the first time, Viola Davis shares her experience with shingles
- Viola encourages adults 50 years and older to prioritize their health and have candid conversations about increased risks that come with aging
- The partnership is part of GSK's new national "Shingles, actually" disease education campaign
PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- GSK plc (LSE/NYSE: GSK) today announced a partnership with award-winning actress, producer and philanthropist Viola Davis to launch "Shingles, actually", a new educational campaign designed to spark conversations about the realities of aging, including the risk of shingles for adults 50 years and older. As part of the "Shingles, actually" campaign, Viola discusses her own experience with shingles for the first time, including its impact on her work and personal life, while encouraging the 50+ community to prioritize their health and start proactive conversations with their doctors.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/gsk/9424351-en-viola-davis-partners-gsk-educate-adults-50-older-shingles-risk
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

7 Undervalued Stocks That Crushed Earnings

This Newly Undervalued Stock Has Plenty of Growth Ahead

Are These Riskier Bond ETFs Worth the Higher Yields?

